Efficacy of escitalopram in acute schizophrenia and depression and its influence on blood parameters with disease
10.3969/j.issn.1005-1678.2017.02.068
- VernacularTitle:艾司西酞普兰治疗急性期精神分裂症伴抑郁患者的效果及对疾病相关血液指标的影响
- Author:
Qun ZHANG
;
Xiaojun WANG
;
Shuwen DU
- Keywords:
escitalopram;
acute schizophrenia;
depression;
application effect;
disease related blood indexes
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(2):223-225
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the application effect of escitalopram in the patients with acute schizophrenia with depression and influence situation for the disease related blood indexes.Methods 84 patients with acute schizophrenia with depression in our hospital from February 2015 to August 2016 were selected as the study object, and they were randomly divided into control group(conventional treatment group)42 cases and observation group( conventional treatment and escitalopram group ) 42 cases, then the total effective rates, plasma free amino acids and stress hormones indexes before and after the treatment of two groups were compared.Results The total effective rates of observation group at different time after the treatment were all higher than those of control group, the difference was statistically significant (P<0.05), the plasma free amino acids after the treatment were all higher than those of control group, the difference was statistically significant (P<0.05), serum stress hormones were all lower than those of control group, the difference was statistically significant (P<0.05), the differences of two groups were all significant.Conclusion The application effect of escitalopram in the patients with acute schizophrenia with depression is better, and it also has active improvement role for the disease related blood indexes of patients.
